Articles from Onego Bio

Onego Bio, a food ingredient company producing non-animal egg protein with precision fermentation*, today announced the launch of a new expert series titled “The Power of Trichoderma reesei: Building the Future with Fungi.” This multi-part initiative reveals the full potential of Trichoderma reesei, the microbial platform behind Onego’s Bioalbumen®, by spotlighting its scientific strengths, industrial scale, and practical performance across food manufacturing.

Onego Bio, a food ingredient company producing egg protein through precision fermentation, announced today that the U.S. Food and Drug Administration (FDA) has issued a “no questions” letter regarding the company’s conclusion that its flagship product, marketed as Bioalbumen®, is Generally Recognized As Safe (GRAS) under its conditions of use in a wide range of food and beverage applications.

Onego Bio, a food ingredient company producing egg protein powder through fermentation, will become the second tenant at Jefferson County’s Food and Beverage Innovation Campus. The $777,000 purchase of 25.9 acres within the campus located on the south side of the City of Jefferson was approved by the Jefferson County Board of Supervisors at its December meeting.

Onego Bio, a Finnish-U.S. food ingredient company, announced the submission of its Generally Recognized as Safe (GRAS) notification to the U.S. Food and Drug Administration (FDA) for its non-animal ovalbumin, produced through precision fermentation using Trichoderma reesei, and branded as Bioalbumen®. This milestone marks a critical step toward bringing the first non-animal egg protein with an amino acid sequence identical to the natural protein, to the global food market.